Zurueck zur Suche

Reporte zur Charge U010742

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

4Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MO 2 FL 1

VAERS 2387942

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U010742

moderat
Staat
-
Alter
10,0
Geschlecht
M
Eingang
25.07.2022
Impfdatum
23.07.2022
Beginn
23.07.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Anxiety Chest pain Headache

Symptomtext

Left sided chest pain, anxiety, headache.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest pain
Hospital-Tage
-
Labordaten
None.
Aktuelle Erkrankungen
No
Vorgeschichte
None
Andere Medikamente
Tylenol as needed, Benadryl as needed
Allergien
No
Vorherige Impfungen
-

VAERS 2355631

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U010742

gering
Staat
MO
Alter
-
Geschlecht
U
Eingang
03.07.2022
Impfdatum
07.06.2022
Beginn
07.06.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product preparation issue

Symptomtext

No additional AEs; vaccine administered after reconstitution with expired sterile diluent; vaccine administered after reconstitution with expired sterile diluent; This spontaneous report has been received from a nurse concerning a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant therapies and drug/allergy history were not reported. On 07-JUN-2022, the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (rHA) (PROQUAD), 0.5 milliliter (ml), administered subcutaneous (lot# U010742, has been verified to be a valid lot number for Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live [rHA] [PROQUAD], expiration date reported as 03-OCT-2022, but upon internal validation established as 02-OCT-2022) as prophylaxis, The vaccine was reconstituted with an expired sterile diluent (manufacturer unknown), 0.5 ml, subcutaneous (lot# S030249, has been verified to be a valid lot number for sterile diluent, expiration date reported as 02-JUN-2022) (Product preparation issue) (Expired product administered). No additional adverse events reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2311697

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U010742

gering
Staat
MO
Alter
4,0
Geschlecht
M
Eingang
07.06.2022
Impfdatum
07.06.2022
Beginn
07.06.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

MMRV was mixed with sterile diluent that expired on 2022Jun02. This nurse is not aware of any adverse reactions by the patient. Contacted MERK and was given the following information: Merk has in house data to support potency of the dose of Merk vaccine/sterile diluent that was inadvertently administered after its labeled expiration date. Stability data indicates that sterile diluent is expected to maintain all quality attributes within the label claim for up to 12 months beyond the labeled expiry. Merk does not make any recommendations on revaccination, that is up to the HCP.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1817128

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) · Charge U010742

gering
Staat
FL
Alter
-
Geschlecht
U
Eingang
26.10.2021
Impfdatum
13.10.2021
Beginn
13.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect product formulation administered

Symptomtext

No additional AE; PROQUAD and VARlVAX instead of VARlVAX and MMR II.; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 13-OCT-2021, the patient was vaccinated with measles (+) mumps (+) rubella (+) varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) (lot# U010742, expiration date was reported as 03-OCT-2022, but upon internal validation established as 02-OCT-2022, 0.5 milliliter in the right thigh) and varicella virus vaccine live (oka/merck) (VARIVAX) (lot# U002397, expiration date 22-JAN-2023, 0.5 ml into left thigh) (formulations, concentrations, dose numbers, frequencies and routes of administration were not reported) for prophylaxis. The measles (+) mumps (+) rubella (+) varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) was administered (instead of measles (+) mumps (+) rubella (Wistar RA 27-3) virus vaccine, live (M-M-R II)) (overdose). Both of administered vaccines were dissolved in sterile diluent lot# T013004, expiration date 13-NOV-2022, 0.7 ml (formulation , strength, route of administration, frequency were not reported). No additional adverse event was reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect product formulation administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-